Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Curevac N.V.

Start price
Target price
Perf. (%)
€50.88
22.06.21
-
17.06.22
-72.98%
18.06.22

Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Amped 
22.06.21 0%
sell
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€46.80
22.06.21
-
17.06.22
4.83%
23.06.21

Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Probably not worthwhile Investment
Amped 
22.06.21 0%
sell
Curevac N.V.

Start price
Target price
Perf. (%)
€49.88
21.06.21
-
17.06.22
2.00%
22.06.21

Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Amped 
21.06.21 0%
sell
Orphazyme A/S

Start price
Target price
Perf. (%)
€6.30
21.06.21
-
21.06.22
9.52%
23.06.21

EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Amped 
21.06.21 0%
sell
Gaussin S.A.

Start price
Target price
Perf. (%)
€7.04
21.06.21
-
21.06.22
10.09%
24.06.21

Revenue growth >5% per year expected
Good rating
ROE higher than 10% per year
Risky balance sheet
Amped 
21.06.21 0%
sell
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€51.76
21.06.21
€45.00
21.06.22
-7.84%
24.06.21

Differentiated customer and product portfolio
Probably not worthwhile Investment
Few uniques
Higher risks for its business
Ellritze 
21.06.21 70%
buy
Nordex SE

Start price
Target price
Perf. (%)
€17.55
21.06.21
-
21.06.22
-9.40%
03.08.21

Mori8 
21.06.21 50%
buy
Orphazyme A/S

Start price
Target price
Perf. (%)
€6.55
21.06.21
-
21.06.22
-3.82%
21.06.21

EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Amped 
21.06.21 0%
buy
Leasinvest Real Estate

Start price
Target price
Perf. (%)
€69.10
20.06.21
€75.00
20.06.22
-14.76%
21.06.22

Could be worthwhile Investment >10% per year
melinda 
20.06.21 50%
buy
Gesco AG NA

Start price
Target price
Perf. (%)
€21.30
20.06.21
€23.00
20.06.22
30.05%
21.06.22

Could be worthwhile Investment >10% per year
melinda 
20.06.21 50%
buy
Freelance.com

Start price
Target price
Perf. (%)
€5.66
19.06.21
€7.00
02.06.22
29.33%
03.06.22

Could be worthwhile Investment >10% per year
melinda 
19.06.21 50%
sell
Freelance.com

Start price
Target price
Perf. (%)
€2.82
19.06.21
€4.00
02.06.22
-
19.06.21

Could be worthwhile Investment >10% per year
melinda 
19.06.21 50%
sell
CropEnergies AG

Start price
Target price
Perf. (%)
€11.58
19.06.21
€9.00
30.12.21
-3.28%
22.06.21

Could be worthwhile Investment >10% per year
melinda 
19.06.21 50%
sell
Seche Environnement

Start price
Target price
Perf. (%)
€50.80
19.06.21
€48.00
19.06.22
12.20%
15.09.21

Could be worthwhile Investment >10% per year
melinda 
19.06.21 50%
sell
Laurent-Perrier S.A.

Start price
Target price
Perf. (%)
€91.80
19.06.21
€88.00
19.06.22
6.97%
20.06.22

Could be worthwhile Investment >10% per year
melinda 
19.06.21 50%
buy
Cafom

Start price
Target price
Perf. (%)
€11.05
19.06.21
€13.00
19.06.22
-2.26%
20.06.22

Could be worthwhile Investment >10% per year
melinda 
19.06.21 50%
buy
SoftBank Group

Start price
Target price
Perf. (%)
€60.20
18.06.21
-
18.06.22
-28.57%
20.01.22

Differentiated customer and product portfolio
Leading role in innovation
High Investments for future growth
Risky balance sheet
NightmareKing 
18.06.21 50%
buy
ATOSS Software AG

Start price
Target price
Perf. (%)
€177.60
18.06.21
€200.00
18.06.22
15.15%
05.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
tbackenh 
18.06.21 80%
buy
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€51.06
17.06.21
-
17.06.22
-8.34%
22.06.21

Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Probably not worthwhile Investment
Amped 
17.06.21 0%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.56
17.06.21
-
17.06.22
2.73%
21.06.21

Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Amped 
17.06.21 0%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.00
17.06.21
€60.00
17.06.22
-40.88%
08.01.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Snowman 
17.06.21 50%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
melinda 
17.06.21 40%
sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€53.25
17.06.21
-
09.03.22
-
17.06.21

Could be very worthwhile Investment >20% year
melinda 
17.06.21 0%
buy
Secureworks Corp

Start price
Target price
Perf. (%)
€17.40
17.06.21
€12.00
17.06.22
-43.68%
17.06.22

Could be worthwhile Investment >10% per year
Innovative
Differentiated customer and product portfolio
Known brand
tbackenh 
17.06.21 50%
buy
co.don AG

Start price
Target price
Perf. (%)
€1.41
17.06.21
-
17.06.23
-13.17%
17.06.23

Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
17.06.21 0%